Citation: Je. Moulder et al., ANGIOTENSIN-II RECEPTOR ANTAGONISTS IN THE TREATMENT AND PREVENTION OF RADIATION NEPHROPATHY, International journal of radiation biology, 73(4), 1998, pp. 415-421
Citation: Je. Moulder et al., RADIATION NEPHROPATHY IS TREATABLE WITH AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR OR AN ANGIOTENSIN-II TYPE-1 (AT(1)) RECEPTOR ANTAGONIST, Radiotherapy and oncology, 46(3), 1998, pp. 307-315
Citation: Ep. Cohen et al., ANGIOTENSIN-II - ENHANCEMENT OF RADIATION NEPHROPATHY (RAD NP), Journal of the American Society of Nephrology, 8, 1997, pp. 2852-2852
Authors:
TWINING SS
SCHULTE DP
ZHOU XY
WILSON PM
FISH BL
MOULDER JE
Citation: Ss. Twining et al., CHANGES IN RAT CORNEAL MATRIX METALLOPROTEINASES AND SERINE PROTEINASES UNDER VITAMIN-A-DEFICIENCY, Current eye research, 16(2), 1997, pp. 158-165
Citation: Je. Moulder et al., NONCONTINUOUS USE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THE TREATMENT OF EXPERIMENTAL BONE-MARROW TRANSPLANT NEPHROPATHY, Bone marrow transplantation, 19(7), 1997, pp. 729-735
Citation: Ep. Cohen et al., SUCCESSFUL BRIEF CAPTOPRIL TREATMENT IN EXPERIMENTAL RADIATION NEPHROPATHY, The Journal of laboratory and clinical medicine, 129(5), 1997, pp. 536-547
Authors:
TWINING SS
SCHULTE DP
WILSON PM
ZHOU XY
FISH BL
MOULDER JE
Citation: Ss. Twining et al., NEUTROPHIL CATHEPSIN-G IS SPECIFICALLY DECREASED UNDER VITAMIN-A-DEFICIENCY, Biochimica et biophysica acta. Molecular basis of disease, 1317(2), 1996, pp. 112-118
Authors:
WARD WF
MOULDER JE
FISH BL
MOLTENI A
GORDON LI
TAYLOR JM
Citation: Wf. Ward et al., ACUTE LUNG REACTIONS IN A RAT MODEL OF POST-BONE MARROW TRANSPLANTATION PNEUMONITIS, The FASEB journal, 10(3), 1996, pp. 627-627
Citation: Je. Moulder et al., ANGIOTENSIN-II RECEPTOR ANTAGONISTS IN THE PREVENTION OF RADIATION NEPHROPATHY, Radiation research, 146(1), 1996, pp. 106-110
Authors:
COHEN EP
MOLTENI A
HILL P
FISH BL
WARD WF
MOULDER JE
CARONE FA
Citation: Ep. Cohen et al., CAPTOPRIL PRESERVES FUNCTION AND ULTRASTRUCTURE IN EXPERIMENTAL RADIATION NEPHROPATHY, Laboratory investigation, 75(3), 1996, pp. 349-360
Authors:
COHEN EP
NORMAN JT
FINE LG
FISH BL
MOULDER JE
Citation: Ep. Cohen et al., PREVENTION OF INTERSTITIAL FIBROBLAST ACTIVATION IN RADIATION NEPHRITIS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1011-1011
Citation: Sj. Li et al., CORRELATION OF RADIOBIOLOGICAL ASSAYS OF HYPOXIC FRACTION WITH P-31 MAGNETIC-RESONANCE SPECTROSCOPY ACROSS MULTIPLE TUMOR LINES, Radiation research, 143(1), 1995, pp. 45-53
Citation: Ca. Lawton et al., EFFECT OF NEPHROTOXIC DRUGS ON THE DEVELOPMENT OF RADIATION NEPHROPATHY AFTER BONE-MARROW TRANSPLANTATION, International journal of radiation oncology, biology, physics, 28(4), 1994, pp. 883-889
Citation: Ep. Cohen et al., PROPHYLAXIS OF EXPERIMENTAL BONE-MARROW TRANSPLANT NEPHROPATHY, The Journal of laboratory and clinical medicine, 124(3), 1994, pp. 371-380
Citation: Ep. Cohen et al., DETERMINANTS OF THERAPEUTIC BENEFIT OF CAPTOPRIL IN ESTABLISHED RADIATION NEPHROPATHY, Clinical research, 42(3), 1994, pp. 10000395-10000395
Citation: Je. Moulder et al., TREATMENT OF RADIATION NEPHROPATHY WITH ACE-INHIBITORS, International journal of radiation oncology, biology, physics, 27(1), 1993, pp. 93-99
Citation: Je. Moulder et al., PROPHYLAXIS OF BONE-MARROW TRANSPLANT NEPHROPATHY WITH CAPTOPRIL, AN INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME, Radiation research, 136(3), 1993, pp. 404-407
Citation: Ep. Cohen et al., TIMING OF CAPTOPRIL TREATMENT FOR EXPERIMENTAL BONE-MARROW TRANSPLANTNEPHROPATHY, Clinical research, 41(3), 1993, pp. 10000677-10000677